Merck brings Welireg-Keytruda combo to treat kidney cancer

June 12, 2026 04:52 PM EDT PharmaFDA+ FDA ap­proves Mer­ck­'s Welireg-Keytru­da com­bo as ad­ju­vant treat­ment for kid­ney can­cer Nicole DeFeudis Senior Reporter Mer­ck’s Welireg and Keytru­da com­bi­na­tion won ap­proval as an ad­ju­vant treat­ment for kid­ney can­cer pa­tients af­ter surgery to re­move all or … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER